Two Sigma Advisers
NARI

Two Sigma Advisers’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Two Sigma Advisers’s Portfolio NARI Stock Details NARI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-76,100
Closed -$3.14M – 2580
2024
Q3 		$3.14M Buy
76,100
+49,200
+183% +$2.36M 0.01% 879
2024
Q2 		$1.3M Buy
+26,900
New +$1.19M ﹤0.01% 1417
2023
Q4 		– Sell
-71,900
Closed -$4.7M – 2675
2023
Q3 		$4.7M Buy
71,900
+39,600
+123% +$2.49M 0.01% 761
2023
Q2 		$1.88M Buy
32,300
+18,100
+127% +$1.14M ﹤0.01% 1231
2023
Q1 		$877K Buy
+14,200
New +$852K ﹤0.01% 1695
2021
Q3 		– Sell
-3,700
Closed -$345K – 2726
2021
Q2 		$345K Buy
+3,700
New +$359K ﹤0.01% 2091

Other funds holding NARI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HM
HCC Manager Chicago, Illinois $10.3M AUM 6.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Two Sigma Advisers's NARI Position: Q4 2024 in Review

Two Sigma Advisers sold out of Inari Medical, Inc. Common Stock (NARI) in Q4 2024, closing a stake of 76,100 shares — an estimated $3.14M sold.

Two Sigma Advisers first reported a position in NARI in Q2 2021 and held it in 6 quarters. The position peaked at $4.7M in Q3 2023. 258 funds tracked by Wall St. Rank hold NARI as of Q4 2024.

  • Two Sigma Advisers reported no remaining Inari Medical, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Two Sigma Advisers sold 76,100 Inari Medical, Inc. Common Stock shares in Q4 2024, an estimated $3.14M.
  • Two Sigma Advisers first reported a position in Inari Medical, Inc. Common Stock in Q2 2021 and held it in 6 quarters.
  • Two Sigma Advisers's Inari Medical, Inc. Common Stock position peaked at $4.7M in Q3 2023.
  • 258 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q4 2024.

Based on Two Sigma Advisers's 13F filing for Q4 2024, filed 14 Feb 2025.